Conference Presentation, Panel
Shifting from Reactive to Proactive Health Care | Asia Summit 2024
Milken InstituteSung Hee Choe, Binayak Dutta, Amit Kakar, Lance Little, Simranjit Singh, Tracey Woon, Simran Singh
- Economic Urgency: Singapore's healthcare spending is projected to rise from $15 billion to $27 billion by 2030, potentially surpassing defense spending as the nation's largest expenditure.
- Demographic Pressure: One in four Singaporeans will be over age 65 by 2030, driving the need to close the "health span" gap where the current reality is living to 84 but spending the final 10 years with chronic disease.
- Strategic Framework (Healthier SG): The initiative aims to shift 20% of healthcare spending from acute hospitals (reactive) to GPs and community partners (preventive) to manage chronic diseases proactively.
- Adoption Metrics: Approximately 1 million citizens have signed up for Healthier SG, utilizing government incentives to engage General Practitioners as the primary hub for preventive care.
- Cancer Mortality Gap: While early-stage (Stage 0/1) colorectal cancer detection yields a >90% 5-year survival rate, 73% of cases are currently detected at Stage 3/4, resulting in only a 14% 5-year survival rate.
- Screening Compliance Barriers: Colorectal cancer screening compliance in Singapore is as low as 27–37% globally, primarily due to the inconvenience of traditional methods like colonoscopies; liquid biopsy tests aim to improve this by simplifying the workflow.
- Behavioral Barriers: Lance Little (Roche Diagnostics) notes that behavioral inertia and stigma prevent effective uptake of available technologies, citing that nearly 15 years after discovering HPV as the cause of cervical cancer, screening rates remain insufficient.
- Self-Sampling Innovation: Roche Diagnostics implemented self-sampling for HPV testing in Asia-Pacific, resulting in 14,000 additional women screened compared to the previous standard.
- Stigma in Hepatitis: Surveys reveal that 58% of the general population believes individuals with hepatitis acquired via needle or drug transmission "deserve" their condition, creating significant barriers to testing.
- Workforce Shortage: Asia faces a projected shortfall of 18 million healthcare professionals by 2030, necessitating efficiency gains through technology and automation.
- Protection Gap: The health insurance protection gap in Asia is estimated at $1 trillion by the end of 2023, exacerbated by 10% annual increases in medical costs.
- Consumer Willingness: Post-pandemic research indicates 51% of Asian consumers are willing to increase out-of-pocket spending for better health outcomes, a figure rising to 60% among younger demographics.
- Financial Incentive Misalignment: Amit Pekar (Novo Holdings) identifies the core market failure: providers and pharmaceutical companies profit from treating advanced disease rather than preventing it, with the majority of revenue tied to procedures and therapies.
- AI Diagnostics: Novo Holdings is investing in AI to transform early detection, such as using AI on chest X-rays to identify lung nodules or tuberculosis before symptoms manifest.
- Telehealth Sustainability: Roche Diagnostics observed that telehealth adoption persists only in markets where funding mechanisms allow clinicians to bill for virtual consults; reimbursement cessation leads to technology abandonment.
- Data-Driven Insurance: FWD Group is leveraging wearable data and "propensity modeling" to price insurance dynamically based on real-time health metrics like blood pressure and pulse rates.
- Generative AI Use Cases: FWD is deploying generative AI for virtual health coaching and to simulate health outcomes for more accurate risk pricing and personalized product propositions.
- Regulatory Friction: Simran Singh (Garden Health) highlights that slow regulatory approval processes hinder the deployment of new technologies like liquid biopsies and genomics compared to emergency approval speeds seen during the pandemic.
- Japan Model: A Japanese public-private "Scrum Initiative" for cancer genomics involved 230 hospitals and 19 biopharma companies, resulting in 12 regulatory approvals and widespread reimbursement for genomic diagnostics within five years.
- Behavioral Nudges: Singapore has successfully reduced smoking rates by increasing the physical inconvenience of obtaining cigarettes and restricting smoking zones, alongside traffic-light food labeling to encourage lower sugar consumption.
- Call to Action: Tracy Woon (NUHS) urges immediate patient engagement, specifically calling on individuals to visit their family doctors and commit to the preventive care pathway established by Healthier SG.